Transforming Biopharma

Transforming Biopharma

Download on the App Store

All Transforming Biopharma episodes

  • Advancing pharma research for everyone: The clinical site perspective

    Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith of Charter Research on how pharma can forge successful partnerships. While good communication, transparency and collaboration are key, they also discuss how investing in site engagement and understanding the challenges and needs of sites can improve the clinical trial process. 

    Highlights include:

    • What sites have learned about recruiting diverse cohorts of patients
    • What kinds of companies are doing site engagement successfully
    • Why it’s important to keep patients at the forefront
    44 min
  • ‘Culture is critical to performance’: Aligning values and strategy with Paul Ingram

    What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with Paul Ingram, professor of business at Columbia University, to explore the critical role of culture and organizational dynamics in driving successful transformation. Ingram, an expert on leadership and strategy, talks about the relationship between individuals, their values and beliefs and how that connects to an organization’s overall culture. 

    46 min
  • Beyond process improvement: Why organizational architecture matters with Mike Tushman

    Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing successful strategies and “exploration” of what they might build for the future. He also discusses the role of leaders in driving transformation and the potential of generative AI.

    36 min
  • Navigating the system, meeting patients where they are with Oya Gilbert

    How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple myeloma patient. They also talk about Oya’s work with the Health, Hope and Hip-Hop Foundation, which aims to use hip-hop culture to promote health literacy in underserved communities. Covering the importance of authenticity and trust in healthcare, as well as the need for education and empowerment for patients, this conversation highlights the importance of understanding each individual’s unique experience and addressing their specific needs.

    48 min
  • From data collection to data connection: Reinventing pharma’s commercial model

    How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial model. Carolyn Morrow, Namita Powers, Srihari Sarangan and Karthik Sourirajan talk about how pharma can create behavior-changing, personalized customer engagement at scale and how companies will need to rethink data collection to achieve data connection. 

    43 min
  • Resetting how we think about obesity: A patient’s point of view

    Recent headlines about the use of prescription drugs for weight loss make obesity a prominent and relevant topic in today’s discussions about health and well-being. Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clinical psychologist and owner, Small Brooklyn Psychology, join Maria Whitman to talk about the underlying challenges obesity presents to society and healthcare, even as new treatments emerge.

    43 min
  • Living with myeloma: Patient advocate Yelak Biru’s story

    Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joins Maria Whitman to talk about his patient experience and how it shaped his perspective as the leader of the first and largest global organization focusing specifically on multiple myeloma. He also talks about how evolving tools and technology like AI can be used to create personalized patient experience, how his passion for data and analytics informs his work today and the key areas where biopharma can engage to better support patients on their journey.

    38 min
  • Disruptors, influencers and the modern customer experience with Arun Shastri

    As biopharma transforms its commercial model, what can it learn from other industries? To find out, Maria Whitman sits down with Arun Shastri, global AI practice lead at ZS. Arun’s an expert on how organizations are modernizing their customer experience and the technology and mindset needed for success. He discusses key principles for the modern sales organization, the real potential of artificial intelligence and how companies can unlock success. Hear how pharma can learn from disruptors, influencers and innovators everywhere.

    44 min
  • On the path to digital transformation with Madhavi Ramakrishna


    Madhavi Ramakrishna, global vice president and chief digital officer of commercial, GSK, is passionate about data and technology. A former executive in broadcast media, she’s now at the forefront of adopting analytics to drive commercial success in biopharma. In this episode, she shares her definition of digital transformation and discusses the biggest opportunities she sees for innovation in pharma’s commercial model. She also discusses what pharma can learn about digital success from companies like Nike and Apple, how pharma can best realize generative AI’s potential and her vision of what successful digital transformation in pharma might look like.

    31 min
  • ‘Patients first, people always’: Science and strategy with Savitri Basavaiah


    Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broader challenges of commercial leadership and what the future might look like as pharma reimagines its commercial model. She also discusses what pharma should do next at a moment when the pace of innovation is incredibly fast and the challenges are unprecedented; why a growth mindset is critical as the industry thinks about the skills and capabilities it needs for the future; and why inclusive leadership is the key to unlocking value for patients.

    27 min